A randomized, double-blind, placebo-controlled dose-finding trial of intravenous immunoglobulin (IVIG; Octagam® 10%, Octapharma AG) in patients with mild to moderate Alzheimer's disease (GAM10-04)
Dodel, Richard, Rominger, Axel, Blennow, Kaj, Barkhof, Frederik, Wietek, Stefan, Haag, Stefan, Bartenstein, Peter, Farlow, Martin, Jessen, FrankVolume:
7
Langue:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2011.09.107
Date:
July, 2011
Fichier:
PDF, 87 KB
english, 2011
File converter
Plus de résultats de recherche
More benefits 
